Open AccessLetter10.1097/jto.0000000000000575

A Case of Squamous Cell Carcinoma Harboring an EML4-ALK Rearrangement that Was Unsuccessfully Treated with the ALK Inhibitor Alectinib

Akihiro Tamiya,Shigeki Shimizu,Shinji Atagi-2015-07-23-Journal of Thoracic Oncology

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

CrizotinibAnaplastic lymphoma kinaseAlectinibPathologyMedicineImmunohistochemistryCytokeratinCarcinoma

Chat

Click to start Chat